3,4-dihydroxyphenylacetic acid and quipazine

3,4-dihydroxyphenylacetic acid has been researched along with quipazine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Achilli, G; Algeri, S; Calderini, G; Consolazione, A; Ponzio, F; Rocchetti, M1
Achilli, G; Algeri, S; Perego, C; Ponzio, F1
Ahlborn, EN; Bailey, SP; Davis, JM1
Benvenga, MJ; Bymaster, FP; Calligaro, DO; Cohen, IR; Falcone, JF; Hemrick-Luecke, SK; Martin, FM; Moore, NA; Nelson, DL; Nisenbaum, LK; Rasmussen, K; Schaus, JM; Sundquist, SJ; Tupper, DE; Wiernicki, TR1

Other Studies

4 other study(ies) available for 3,4-dihydroxyphenylacetic acid and quipazine

ArticleYear
Biochemical effects of quipazine on rat striatal dopaminergic system.
    Life sciences, 1981, Jul-06, Volume: 29, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Metergoline; Methyltyrosines; Pargyline; Quinolines; Quipazine; Rats

1981
Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Neuroscience letters, 1981, Nov-18, Volume: 27, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clozapine; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Nomifensine; Phenylacetates; Piribedil; Quipazine; Rats

1981
Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue.
    Journal of applied physiology (Bethesda, Md. : 1985), 1993, Volume: 74, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Glucose; Brain; Dopamine; Ergolines; Fatigue; Fatty Acids, Nonesterified; Glycogen; Male; Physical Exertion; Quipazine; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists

1993
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Catalepsy; Cocaine; Corticosterone; Drug Evaluation, Preclinical; Electrochemistry; Electrophysiology; Fasting; Female; Immunohistochemistry; Male; Molecular Structure; Motor Activity; Nucleus Accumbens; Olanzapine; Piperazines; Prolactin; Quipazine; Radioligand Assay; Rats; Rats, Inbred F344; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Histamine H1; Serotonin Receptor Agonists; Thiophenes; Time Factors

2005